Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiac Rehabilitation | 31 | 2025 | 67 | 12.660 |
Why?
|
Heart Diseases | 10 | 2022 | 206 | 3.500 |
Why?
|
Hospitalization | 16 | 2023 | 1304 | 2.650 |
Why?
|
Cardiovascular Diseases | 9 | 2025 | 831 | 2.520 |
Why?
|
Smoking Cessation | 10 | 2019 | 538 | 2.320 |
Why?
|
Exercise Test | 6 | 2023 | 237 | 2.240 |
Why?
|
Cardiology | 8 | 2025 | 163 | 2.120 |
Why?
|
Patient Compliance | 5 | 2019 | 373 | 1.950 |
Why?
|
Coronary Disease | 4 | 2023 | 250 | 1.920 |
Why?
|
Patient Acceptance of Health Care | 5 | 2019 | 455 | 1.710 |
Why?
|
Exercise Therapy | 9 | 2025 | 102 | 1.690 |
Why?
|
Inpatients | 8 | 2023 | 300 | 1.660 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2017 | 157 | 1.460 |
Why?
|
Exercise | 9 | 2023 | 919 | 1.450 |
Why?
|
Cardiac Surgical Procedures | 3 | 2021 | 253 | 1.440 |
Why?
|
Outpatients | 7 | 2019 | 140 | 1.440 |
Why?
|
Patient Participation | 5 | 2023 | 214 | 1.380 |
Why?
|
Coronary Artery Bypass | 5 | 2022 | 276 | 1.270 |
Why?
|
Humans | 76 | 2025 | 60096 | 1.180 |
Why?
|
Echocardiography | 2 | 2023 | 460 | 1.180 |
Why?
|
Patient Readmission | 6 | 2023 | 424 | 1.150 |
Why?
|
Quality Improvement | 3 | 2018 | 428 | 1.090 |
Why?
|
United States | 31 | 2025 | 7608 | 1.020 |
Why?
|
Middle Aged | 32 | 2024 | 16543 | 1.000 |
Why?
|
Aged | 34 | 2024 | 13584 | 1.000 |
Why?
|
Heart Valve Diseases | 2 | 2016 | 88 | 0.970 |
Why?
|
Smoking | 3 | 2019 | 835 | 0.960 |
Why?
|
Preventive Medicine | 3 | 2015 | 25 | 0.910 |
Why?
|
Retrospective Studies | 22 | 2023 | 6139 | 0.870 |
Why?
|
Smokers | 3 | 2019 | 112 | 0.870 |
Why?
|
Nicotine | 2 | 2018 | 111 | 0.850 |
Why?
|
Cigarette Smoking | 1 | 2023 | 52 | 0.840 |
Why?
|
Quality Indicators, Health Care | 4 | 2018 | 331 | 0.840 |
Why?
|
Female | 40 | 2024 | 31229 | 0.840 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 570 | 0.840 |
Why?
|
Fear | 1 | 2023 | 67 | 0.830 |
Why?
|
Male | 37 | 2024 | 27963 | 0.830 |
Why?
|
Coronary Artery Disease | 3 | 2014 | 275 | 0.810 |
Why?
|
Internship and Residency | 3 | 2024 | 748 | 0.800 |
Why?
|
Self Efficacy | 1 | 2023 | 199 | 0.790 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2022 | 13 | 0.790 |
Why?
|
Coronary Stenosis | 1 | 2022 | 31 | 0.780 |
Why?
|
Ambulatory Care | 2 | 2014 | 306 | 0.750 |
Why?
|
Percutaneous Coronary Intervention | 2 | 2022 | 171 | 0.750 |
Why?
|
Weight Loss | 2 | 2014 | 264 | 0.740 |
Why?
|
Surveys and Questionnaires | 6 | 2023 | 2614 | 0.730 |
Why?
|
Fellowships and Scholarships | 2 | 2012 | 102 | 0.730 |
Why?
|
Binge Drinking | 1 | 2021 | 29 | 0.730 |
Why?
|
Accidental Falls | 1 | 2022 | 153 | 0.720 |
Why?
|
Electrocardiography | 1 | 2023 | 529 | 0.700 |
Why?
|
Cost Sharing | 1 | 2019 | 14 | 0.670 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2020 | 65 | 0.670 |
Why?
|
Walking | 2 | 2023 | 230 | 0.660 |
Why?
|
Patient Dropouts | 1 | 2019 | 48 | 0.650 |
Why?
|
Patient Education as Topic | 2 | 2020 | 450 | 0.640 |
Why?
|
Motivation | 2 | 2019 | 270 | 0.640 |
Why?
|
Tobacco Use Disorder | 2 | 2019 | 245 | 0.610 |
Why?
|
Heart Failure | 7 | 2023 | 868 | 0.610 |
Why?
|
Health Services Accessibility | 3 | 2024 | 546 | 0.600 |
Why?
|
Cardiology Service, Hospital | 1 | 2018 | 16 | 0.600 |
Why?
|
Alcoholism | 1 | 2021 | 308 | 0.590 |
Why?
|
Myocardial Infarction | 3 | 2020 | 869 | 0.590 |
Why?
|
Obesity | 3 | 2014 | 1191 | 0.570 |
Why?
|
Lung Diseases | 1 | 2018 | 166 | 0.540 |
Why?
|
Atrial Fibrillation | 3 | 2020 | 805 | 0.540 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2016 | 7 | 0.540 |
Why?
|
Postoperative Complications | 3 | 2019 | 1175 | 0.520 |
Why?
|
Practice Patterns, Physicians' | 2 | 2019 | 718 | 0.510 |
Why?
|
Follow-Up Studies | 7 | 2019 | 2360 | 0.510 |
Why?
|
Decision Making | 1 | 2019 | 394 | 0.490 |
Why?
|
Patient Transfer | 1 | 2016 | 91 | 0.490 |
Why?
|
Mitral Valve | 1 | 2016 | 105 | 0.480 |
Why?
|
Heart Rate | 3 | 2023 | 308 | 0.480 |
Why?
|
Referral and Consultation | 4 | 2022 | 409 | 0.470 |
Why?
|
Employment | 1 | 2015 | 136 | 0.460 |
Why?
|
Aortic Valve | 1 | 2016 | 172 | 0.460 |
Why?
|
Postoperative Care | 1 | 2014 | 114 | 0.460 |
Why?
|
Pilot Projects | 3 | 2023 | 930 | 0.450 |
Why?
|
Telemedicine | 1 | 2019 | 337 | 0.450 |
Why?
|
Health Care Surveys | 1 | 2015 | 281 | 0.450 |
Why?
|
Patient Discharge | 3 | 2020 | 483 | 0.440 |
Why?
|
Physical Therapy Modalities | 1 | 2013 | 45 | 0.420 |
Why?
|
Medicare | 6 | 2024 | 599 | 0.400 |
Why?
|
Appointments and Schedules | 1 | 2012 | 54 | 0.400 |
Why?
|
Aged, 80 and over | 12 | 2021 | 5195 | 0.390 |
Why?
|
Prescriptions | 2 | 2022 | 33 | 0.390 |
Why?
|
Exercise Tolerance | 2 | 2022 | 71 | 0.370 |
Why?
|
Guidelines as Topic | 1 | 2012 | 157 | 0.370 |
Why?
|
Risk Assessment | 5 | 2021 | 1934 | 0.360 |
Why?
|
American Heart Association | 4 | 2025 | 128 | 0.350 |
Why?
|
Adipose Tissue | 1 | 2013 | 284 | 0.350 |
Why?
|
Databases, Factual | 4 | 2018 | 849 | 0.340 |
Why?
|
Nurses | 2 | 2021 | 104 | 0.320 |
Why?
|
Time Factors | 6 | 2021 | 3619 | 0.320 |
Why?
|
Incidence | 3 | 2022 | 1266 | 0.310 |
Why?
|
Counseling | 3 | 2021 | 352 | 0.300 |
Why?
|
Nicotinic Agonists | 1 | 2008 | 39 | 0.300 |
Why?
|
Acute Disease | 3 | 2019 | 661 | 0.300 |
Why?
|
Minnesota | 4 | 2016 | 38 | 0.300 |
Why?
|
Curriculum | 1 | 2012 | 570 | 0.290 |
Why?
|
Survival Rate | 4 | 2019 | 793 | 0.290 |
Why?
|
Risk Factors | 8 | 2021 | 5086 | 0.290 |
Why?
|
Smoking Prevention | 1 | 2008 | 162 | 0.280 |
Why?
|
Single-Blind Method | 3 | 2023 | 136 | 0.280 |
Why?
|
Reproducibility of Results | 5 | 2018 | 1564 | 0.280 |
Why?
|
Length of Stay | 4 | 2019 | 781 | 0.270 |
Why?
|
Hospital Mortality | 4 | 2019 | 856 | 0.260 |
Why?
|
Social Class | 2 | 2023 | 126 | 0.250 |
Why?
|
Healthcare Disparities | 2 | 2020 | 332 | 0.240 |
Why?
|
Treatment Outcome | 7 | 2019 | 5264 | 0.240 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 1034 | 0.230 |
Why?
|
Prognosis | 4 | 2016 | 1591 | 0.230 |
Why?
|
Certification | 1 | 2024 | 49 | 0.220 |
Why?
|
Massachusetts | 2 | 2019 | 2119 | 0.210 |
Why?
|
Logistic Models | 2 | 2021 | 1260 | 0.200 |
Why?
|
Habits | 1 | 2022 | 21 | 0.200 |
Why?
|
Physical Exertion | 1 | 2022 | 78 | 0.190 |
Why?
|
Heart Transplantation | 1 | 2023 | 159 | 0.190 |
Why?
|
Attitude | 1 | 2022 | 101 | 0.190 |
Why?
|
Oxygen Consumption | 1 | 2022 | 203 | 0.180 |
Why?
|
Depression | 2 | 2018 | 867 | 0.180 |
Why?
|
Alcohol-Related Disorders | 1 | 2021 | 36 | 0.180 |
Why?
|
Yoga | 1 | 2020 | 15 | 0.170 |
Why?
|
Alcohol Drinking | 1 | 2022 | 305 | 0.170 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 2501 | 0.170 |
Why?
|
Amiodarone | 1 | 2019 | 21 | 0.160 |
Why?
|
Health Status | 1 | 2022 | 451 | 0.160 |
Why?
|
Atrial Flutter | 1 | 2019 | 21 | 0.160 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 679 | 0.160 |
Why?
|
Hospitals | 2 | 2023 | 377 | 0.160 |
Why?
|
Potassium | 1 | 2019 | 110 | 0.160 |
Why?
|
Telephone | 1 | 2019 | 121 | 0.160 |
Why?
|
Postoperative Period | 2 | 2016 | 127 | 0.160 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 93 | 0.150 |
Why?
|
Income | 1 | 2019 | 162 | 0.150 |
Why?
|
Wound Healing | 1 | 2019 | 177 | 0.150 |
Why?
|
Surgical Procedures, Operative | 1 | 2019 | 139 | 0.150 |
Why?
|
Intention | 1 | 2018 | 65 | 0.150 |
Why?
|
Life Style | 1 | 2020 | 330 | 0.150 |
Why?
|
Double-Blind Method | 1 | 2019 | 680 | 0.140 |
Why?
|
Dyspnea | 1 | 2018 | 110 | 0.140 |
Why?
|
Feasibility Studies | 1 | 2019 | 531 | 0.140 |
Why?
|
Pandemics | 1 | 2022 | 629 | 0.140 |
Why?
|
Secondary Prevention | 3 | 2025 | 154 | 0.140 |
Why?
|
Plethysmography | 2 | 2014 | 10 | 0.140 |
Why?
|
Patient Satisfaction | 1 | 2019 | 419 | 0.130 |
Why?
|
Activities of Daily Living | 1 | 2018 | 300 | 0.130 |
Why?
|
Emergencies | 1 | 2016 | 114 | 0.130 |
Why?
|
Myocardial Revascularization | 1 | 2016 | 72 | 0.130 |
Why?
|
Physicians | 1 | 2021 | 442 | 0.130 |
Why?
|
Erythrocyte Transfusion | 1 | 2016 | 76 | 0.130 |
Why?
|
Mass Screening | 1 | 2021 | 665 | 0.130 |
Why?
|
Blood Pressure | 1 | 2018 | 522 | 0.120 |
Why?
|
Return to Work | 1 | 2015 | 25 | 0.120 |
Why?
|
Anxiety | 1 | 2018 | 400 | 0.120 |
Why?
|
Adult | 7 | 2024 | 15980 | 0.120 |
Why?
|
Skinfold Thickness | 1 | 2014 | 16 | 0.120 |
Why?
|
Program Evaluation | 1 | 2017 | 488 | 0.120 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 193 | 0.120 |
Why?
|
Decision Support Techniques | 1 | 2016 | 183 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 743 | 0.120 |
Why?
|
Models, Cardiovascular | 1 | 2015 | 77 | 0.110 |
Why?
|
Advisory Committees | 1 | 2015 | 107 | 0.110 |
Why?
|
Morbidity | 1 | 2014 | 110 | 0.110 |
Why?
|
Stress, Psychological | 1 | 2018 | 451 | 0.110 |
Why?
|
Insurance Coverage | 1 | 2014 | 98 | 0.110 |
Why?
|
Forecasting | 1 | 2014 | 221 | 0.110 |
Why?
|
Body Mass Index | 2 | 2015 | 892 | 0.110 |
Why?
|
Societies, Medical | 3 | 2025 | 342 | 0.110 |
Why?
|
Propensity Score | 3 | 2020 | 138 | 0.110 |
Why?
|
Insurance, Health | 1 | 2014 | 143 | 0.110 |
Why?
|
Global Health | 1 | 2014 | 165 | 0.110 |
Why?
|
Waist Circumference | 1 | 2013 | 53 | 0.100 |
Why?
|
Comorbidity | 1 | 2016 | 1097 | 0.100 |
Why?
|
Body Height | 1 | 2013 | 75 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 391 | 0.100 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 319 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2013 | 229 | 0.100 |
Why?
|
Young Adult | 3 | 2016 | 4394 | 0.090 |
Why?
|
Body Weight | 1 | 2013 | 381 | 0.090 |
Why?
|
Adolescent | 3 | 2016 | 5957 | 0.090 |
Why?
|
Data Collection | 1 | 2012 | 382 | 0.090 |
Why?
|
Cohort Studies | 3 | 2021 | 2477 | 0.090 |
Why?
|
Physician's Role | 1 | 2011 | 120 | 0.080 |
Why?
|
Chewing Gum | 1 | 2008 | 7 | 0.080 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2007 | 86 | 0.060 |
Why?
|
Aspirin | 1 | 2007 | 172 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2007 | 218 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 685 | 0.050 |
Why?
|
Benzimidazoles | 1 | 2004 | 59 | 0.050 |
Why?
|
Waiting Lists | 1 | 2023 | 48 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 121 | 0.050 |
Why?
|
Patient Outcome Assessment | 1 | 2023 | 55 | 0.050 |
Why?
|
Metabolic Equivalent | 1 | 2022 | 13 | 0.050 |
Why?
|
Patients | 1 | 2022 | 103 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2018 | 457 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2004 | 311 | 0.040 |
Why?
|
Symptom Flare Up | 1 | 2020 | 13 | 0.040 |
Why?
|
Caregivers | 1 | 2023 | 232 | 0.040 |
Why?
|
Fee-for-Service Plans | 1 | 2020 | 66 | 0.040 |
Why?
|
Time-to-Treatment | 1 | 2020 | 99 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 61 | 0.040 |
Why?
|
DNA | 1 | 2004 | 793 | 0.040 |
Why?
|
Regression Analysis | 1 | 2020 | 483 | 0.040 |
Why?
|
Perception | 1 | 2020 | 179 | 0.040 |
Why?
|
Survival Analysis | 1 | 2020 | 558 | 0.040 |
Why?
|
Data Warehousing | 1 | 2018 | 8 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 735 | 0.040 |
Why?
|
Consensus | 1 | 2018 | 199 | 0.030 |
Why?
|
Administrative Claims, Healthcare | 1 | 2016 | 12 | 0.030 |
Why?
|
Recovery of Function | 1 | 2018 | 267 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 125 | 0.030 |
Why?
|
Data Mining | 1 | 2016 | 47 | 0.030 |
Why?
|
Qualitative Research | 1 | 2020 | 633 | 0.030 |
Why?
|
ROC Curve | 1 | 2016 | 260 | 0.030 |
Why?
|
Models, Statistical | 1 | 2016 | 309 | 0.030 |
Why?
|
Disease Progression | 1 | 2019 | 1054 | 0.030 |
Why?
|
Biomarkers | 1 | 2019 | 1212 | 0.030 |
Why?
|
Observer Variation | 1 | 2014 | 203 | 0.030 |
Why?
|
Medical Records | 1 | 2014 | 139 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2016 | 355 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 125 | 0.030 |
Why?
|
Population Surveillance | 1 | 2014 | 206 | 0.030 |
Why?
|
Odds Ratio | 1 | 2014 | 773 | 0.030 |
Why?
|
Recurrence | 1 | 2014 | 600 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 1100 | 0.020 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2011 | 6 | 0.020 |
Why?
|
Wisconsin | 1 | 2011 | 15 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2011 | 45 | 0.020 |
Why?
|
Medical Audit | 1 | 2011 | 60 | 0.020 |
Why?
|
Disease Management | 1 | 2011 | 222 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 248 | 0.020 |
Why?
|
Gram-Positive Bacteria | 1 | 2004 | 36 | 0.010 |
Why?
|
Drug Resistance, Bacterial | 1 | 2004 | 82 | 0.010 |
Why?
|
Ligands | 1 | 2004 | 420 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 1555 | 0.010 |
Why?
|
Mice | 1 | 2004 | 10331 | 0.010 |
Why?
|
Animals | 1 | 2004 | 19749 | 0.000 |
Why?
|